TrialBMJ open respiratory research2020

Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial.

Toru Arai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.